Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S C, van der Schoot"'
Autor:
S C, van der Schoot, L D, Vainchtein, B, Nuijen, A, Gore, D, Mirejovsky, L, Lenaz, J H, Beijnen
Publikováno v:
Die Pharmazie. 63(11)
Two new bladder instillations of the investigational anticancer agent EO-9 containing 2-hydroxypropyl-beta-cyclodextrin (HP beta CD) and the alkalizers sodium bicarbonate (NaHCO3) and tri(hydroxymethyl)aminomethane (Tris) were developed. During the s
Autor:
J. H. Beijnen, Dorla Mirejovsky, Luigi Lenaz, Frits M. Flesch, S. C. van der Schoot, Bastiaan Nuijen, Ashok Gore
Publikováno v:
Drug development and industrial pharmacy. 34(10)
For the development of a bladder instillation of the indoloquinone agent EO-9, use of the complexing agent 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) was considered. Therefore, a complexation study of EO-9 with HPbetaCD was performed. Complexation
Autor:
S C, Van der Schoot, B, Nuijen, P, Sood, K B, Thurmond, D R, Stewart, J R, Rice, J H, Beijnen
Publikováno v:
Die Pharmazie. 61(10)
AP5346 is a low molecular weight polymer-conjugated platinum antineoplastic agent. The lyophilized drug product has completed a phase I clinical trial. In order to guarantee a constant quality of AP5346 pharmaceutical products, quality control and an
Publikováno v:
Pharmaceutical Research
Purpose To identify the magnitude and sources of variability of a generic, aseptic manufacturing process for experimental anticancer agents employed at our facility, and to estimate the effects on product quality. Materials and Methods In-process and